Tectonic Therapeutic | AVRO - Ingresos Por Ventas

Precio De Mercado
27.42
Cambio Diario
0.01 0.04%
Mensual
12.52%
Anual
20.74%
Q1 Expectativa
22.73




Ventas Cambio Fecha
Akebia Therapeutics USD 57.34M 10.84M 2025-03
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Celltrion KRW 1.33T 300B 2026-03
Cspc Pharmaceutical CNY 6.62B 358.95M 2025-09
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 396K 203K 2025-09
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma EUR 448.66M 67.82M 2023-12
MacroGenics USD 72.84M 50.6M 2025-09
Medical Developments International AUD 21.57M 12.04M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 80.06M 9.27M 2025-09
Pfizer USD 17.58B 880M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 17.57B 4.58B 2025-06
Takeda JPY 1.19T 80B 2025-12
Tilray USD 217.51M 74.75M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09